slotkoers
Korea S.E.
00:00:00 17-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
3.165
KRW
|
-0,16%
|
|
0,00%
|
-49,12%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
88.980
|
105.582
|
117.396
|
46.147
|
84.355
|
Bedrijfswaarde
1 |
89.506
|
107.701
|
117.767
|
68.696
|
89.988
|
K/w-verhouding
|
-9,71
x
|
3,06
x
|
-3,36
x
|
-1,86
x
|
-3,82
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
651
x
|
67,2
x
|
38,5
x
|
18
x
|
32,4
x
|
Bedrijfswaarde/omzet
|
655
x
|
68,5
x
|
38,7
x
|
26,8
x
|
34,6
x
|
Bedrijfswaarde/EBITDA
|
-15,7
x
|
-11,8
x
|
-9,56
x
|
-6,48
x
|
-8,19
x
|
Bedrijfswaarde/FCF
|
-
|
-9.415.578
x
|
-22.129.822
x
|
-3.481.451
x
|
-12.472.392
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
573
x
|
1,98
x
|
3,81
x
|
7,31
x
|
6,13
x
|
Aantal aandelen (in duizenden)
|
5.393
|
6.399
|
6.558
|
6.669
|
13.562
|
Referentieprijs
2 |
16.500
|
16.500
|
17.900
|
6.920
|
6.220
|
Datum van publicatie
|
18/03/21
|
18/03/21
|
23/03/22
|
23/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
136,6
|
1.572
|
3.047
|
2.559
|
2.600
|
EBITDA
1 |
-5.691
|
-9.153
|
-12.313
|
-10.595
|
-10.985
|
Bedrijfsresultaat (EBIT)
1 |
-6.560
|
-9.267
|
-12.745
|
-11.510
|
-12.376
|
Operationele Marge
|
-4.801,54%
|
-589,48%
|
-418,29%
|
-449,69%
|
-475,93%
|
Resultaat voor belastingen (EBT)
1 |
-9.162
|
32.966
|
-35.150
|
-25.452
|
-20.295
|
Nettowinst (verlies)
1 |
-9.162
|
33.108
|
-34.670
|
-24.597
|
-19.260
|
Nettomarge
|
-6.706,46%
|
2.106,14%
|
-1.137,86%
|
-961,01%
|
-740,68%
|
WPA
2 |
-1.699
|
5.399
|
-5.324
|
-3.721
|
-1.629
|
Free Cash Flow
|
-
|
-11.439
|
-5.322
|
-19.732
|
-7.215
|
FCF-marge
|
-
|
-727,65%
|
-174,65%
|
-770,94%
|
-277,47%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
18/03/21
|
18/03/21
|
23/03/22
|
23/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
526
|
2.119
|
371
|
22.549
|
5.633
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-0,0925
x
|
-0,2315
x
|
-0,0301
x
|
-2,128
x
|
-0,5128
x
|
Free Cash Flow
|
-
|
-11.439
|
-5.322
|
-19.732
|
-7.215
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
122%
|
-82,7%
|
-139%
|
-228%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-17,5%
|
-13,4%
|
-15,5%
|
-21,9%
|
Totale activa
1 |
-
|
-189.692
|
259.545
|
158.187
|
88.074
|
Nettoactief per aandeel
2 |
28,80
|
8.342
|
4.694
|
947,0
|
1.014
|
Cashflow per aandeel
2 |
104,0
|
879,0
|
1.824
|
878,0
|
216,0
|
Capex
1 |
815
|
1.124
|
1.076
|
13.046
|
2.056
|
Capex/omzet
|
596,44%
|
71,52%
|
35,3%
|
509,71%
|
79,06%
|
Datum van publicatie
|
18/03/21
|
18/03/21
|
23/03/22
|
23/03/23
|
20/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -49,12% | 33,78 mln. | | -4,62% | 12,32 mld. | | -5,19% | 8,07 mld. | | +8,00% | 5,91 mld. | | +28,50% | 5,52 mld. | | -8,09% | 4,21 mld. | | +13,49% | 2,73 mld. | | -2,98% | 2,43 mld. | | +32,24% | 2,29 mld. | | -3,55% | 1,89 mld. |
Diagnostische en teststoffen
|